Nuvalent, Inc. · NASDAQ:NUVL
Pelish Henry E. sold 3,093 Nuvalent, Inc. shares (Form 4)
Traded Apr 9, 2026 · Filed Apr 13, 2026
On Apr 9, 2026, Pelish Henry E. (Chief Scientific Officer) sold 3,093 Nuvalent, Inc. shares at an average US$104.48 for US$323K under a trading plan, leaving 65,604 shares. Filed Apr 13, 2026 (Form 4).
- Sold
- 3,093 shares
- Price
- US$104.48 average (US$104.27 to US$105.00)
- Value
- US$323K
- Holding after
- 65,604 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 9, 2026 | Class A Common Stock | Option exercise | 3,093 | US$27.85 | 68,697 | Direct |
| Apr 9, 2026 | Class A Common Stock | Sale | 2,193 | US$104.27 | 66,504 | Direct |
| Apr 9, 2026 | Class A Common Stock | Sale | 900 | US$105.00 | 65,604 | Direct |
Source
Related
- Nuvalent, Inc.
- Pelish Henry E.
- Nuvalent, Inc. shareholders
- Form 4 · Pelish Henry E. · Jul 15, 2026
- Form 4 · Pelish Henry E. · Jul 10, 2026
- Form 4 · Deerfield Private Design Fund IV, L.P. · Jul 17, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Jul 17, 2026
- Form 4 · Meyers Michael L. · Jul 15, 2026
- Form 4 · Balcom Alexandra · Jul 15, 2026
- Form 4 · Srivastava Sapna · Jul 15, 2026